3-amino-N-((tetrahydro-2H-pyran-2-yl)oxy)propanamide | 303038-08-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 3-amino-N-((tetrahydro-2H-pyran-2-yl)oxy)propanamide
• 英文别名: 3-amino-N-(oxan-2-yloxy)propanamide
• CAS: 303038-08-6
• 化学式: C₈H₁₆N₂O₃
• 分子量: 188.227
• InChiKey: GTVPHUNJZMDVGA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  73.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-amino-N-((tetrahydro-2H-pyran-2-yl)oxy)propanamide 、 3-(3-Bromo-4-hydroxy-phenyl)-2-[(E)-tetrahydro-pyran-2-yloxyimino]-propionic acid 2,5-dioxo-pyrrolidin-1-yl ester 在 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 生成
  参考文献：
  名称：

  Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets

  摘要：

  Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC50 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotcodcity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.

  DOI：

  10.1021/jm2016182
• 作为产物：
  描述：

  3-(1,3-dioxoisoindolin-2-yl)-N-(tetrahydro-2H-pyran-2-yloxy)propanamide 在 一水合肼 作用下， 以 甲醇 为溶剂， 反应 2.5h， 以42%的产率得到3-amino-N-((tetrahydro-2H-pyran-2-yl)oxy)propanamide
  参考文献：
  名称：

  Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets

  摘要：

  Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC50 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotcodcity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.

  DOI：

  10.1021/jm2016182

文献信息

• Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
  作者：Nima Rajabi、Tobias N. Hansen、Alexander L. Nielsen、Huy T. Nguyen、Michael Bæk、Julie. E. Bolding、Oskar Ø. Bahlke、Sylvester E. G. Petersen、Christian R. O. Bartling、Kristian Strømgaard、Christian A. Olsen

  DOI：10.1002/anie.202115805

  日期：2022.5.23

  A SAR study of mechanism-based inhibitors of the sirtuin 5 (SIRT5) hydrolase, containing isosteres of an essential carboxylic acid moiety, furnished heterocycles with excellent potency and slow, tight-binding kinetics against the enzyme. Evaluation of selected compounds in cells revealed that transient masking of the heterocycle provided improved inhibitors with a high level of target engagement in

  一项基于机制的 sirtuin 5 (SIRT5) 水解酶抑制剂的 SAR 研究，包含必需羧酸部分的等排体，为杂环提供了优异的效力和对酶的缓慢、紧密结合的动力学。对细胞中选定化合物的评估表明，杂环的瞬时掩蔽提供了改进的抑制剂，在培养的细胞中具有高水平的靶标参与。
• MMP INHIBITOR
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP1171422A1

  公开（公告）日：2002-01-16
• [EN] MMP INHIBITOR<br/>[FR] INHIBITEUR MMP
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2000063165A1

  公开（公告）日：2000-10-26

  The compound of the present invention is useful as a medicament for prophylactic and therapeutic treatment of MMP- or TNF α-mediated diseases.